Drug intelligence / Profile preview

6-hydroxy-1,6-dihydro purine nucleoside

Development stage
Unknown
Modality
Small Molecules
01

Overview

"6-hydroxy–1,6–dihydropurine nucleoside" is a synthetic purine nucleoside analog and a small molecule that acts as a potent inhibitor of adenosine deaminase (ADA), an enzyme critical in purine metabolism. It functions as a transition-state or reaction coordinate analogue for ADA and binds tightly to the enzyme's active site via multiple hydrogen bonds. This compound has been used experimentally to study ADA structure and function but is not approved for clinical use or marketed as a pharmaceutical product. Its primary utility is in biochemical research related to ADA inhibition[1][8][6].

Other names
6-Hydroxy-1,6-Dihydro Purine Nucleoside(6S)-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-hydroxy-6,7-dihydro-3H-9lambda5-purin-9-ylium(6S)-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hydroxy-6,7-dihydro‑3H‑9lambda5‑purin‑9‑ylium(6S)-6-hydroxy‑9-beta-D-ribofuranosyl‑6,9-dihydro‑1H-purin–7–ium
02

Targets

ADA (Adenosine deaminase)

Beyond the preview

Go deeper on 6-hydroxy-1,6-dihydro purine nucleoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-hydroxy-1,6-dihydro purine nucleoside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call